Vacc-4x: Phase I/II data

Data from 6 patients with HIV-1 infection on cART with undetectable HIV-1 RNA levels in Part A of the open-label, Danish Phase I/II REDUC trial showed that 5 mg/m 2 IV Istodax romidepsin -

Read the full 349 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE